Ignite Creation Date:
2025-12-25 @ 4:47 AM
Ignite Modification Date:
2026-01-12 @ 12:26 AM
Study NCT ID:
NCT01337518
Status:
SUSPENDED
Last Update Posted:
2012-12-18
First Post:
2011-04-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer
Sponsor:
Enzon Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EZN-4176-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None